https://www.selleckchem.com/pr....oducts/caspofungin-a
3% (5/79) of the no PET subgroup. The most common follow-up modality after a negative PET scan was a CT scan (47/67, 70.1%), with a median interval of 3.1 months. Clinical variables including nodule location/size, chronic obstructive pulmonary disease, family history of lung cancer, pack-years, and number of years quit in former smokers were not significantly associated with greater cancer risk among PET-negatives. For LungRADS-4/PET-negative lesions, the cancer risk remained high despite lack of activity on PET. As such, we